Skip to Main Content

Paper Details

Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint.
3
2023
BC, HER2, HER2+BC, Invasive Cancer, TNBC, Women, breast cancer, human epidermal growth factor receptor, invasive ductal carcinoma, patients, triple-negative (TNBC) or human epidermal growth factor receptor 2-positive breast cancer
Author NameAffiliation
Benjamin D SmithUniversity of Texas MD Anderson Cancer Center
Yu ShenUniversity of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2